MEDI-4212

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameMEDI-4212
Drug Alias NameImmunoglobulin E targeting antibody (MedImmune)MEDI4212MEDI 4212Anti-IgE antibody (MedImmune)MEDI-4212
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionIgE Fc receptor, alpha-subunit antagonistsImmunoglobulin epsilon Fc receptor antagonists
TargetsIgE Fc receptor, alpha-subunitImmunoglobulin epsilon Fc receptor
Therapy Area/IndicationsDermatitis, AtopicRhinitis, AllergicAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMedimmune Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedimmune Llc
Active IndicationsN/A
Inactive IndicationsDermatitis, AtopicRhinitis, AllergicAsthma

Other Information

ATC CodeN/A
Related LinksN/A